Abstract The human a 1 /His 10 -b 1 isoform of Na,K-ATPase has been reconstituted as a complex with and without FXYD1 into proteoliposomes of various lipid compositions in order to study the effect of the regulatory subunit on the half-saturating Na ? concentration (K 1/2 ) of Na ? ions for activation of the ion pump. It has been shown that the fraction of negatively charged lipid in the bilayer crucially affects the regulatory properties. At low concentrations of the negatively charged lipid DOPS (\10 %), FXYD1 increases K 1/2 of Na ? ions for activation of the ion pump. Phosphorylation of FXYD1 by protein kinase A at Ser68 abrogates this effect. Conversely, for proteoliposomes made with high concentrations of DOPS ([10 %), little or no effect of FXYD1 on the K 1/2 of Na ? ions is observed. Depending on ionic strength and lipid composition of the proteoliposomes, FXYD1 can alter the K 1/2 of Na ? ions by up to twofold. We propose possible molecular mechanisms to explain the regulatory effects of FXYD1 and the influence of charged lipid and protein phosphorylation. In particular, the positively charged C-terminal helix of FXYD1 appears to be highly mobile and may interact with the cytoplasmic N domain of the a-subunit, the interaction being strongly affected by phosphorylation at Ser68 and the surface charge of the membrane.
Introduction
Na,K-ATPase is an integral membrane protein present in virtually all animal cells, where it transports Na ? and K
?
ions across the plasma membrane against their electrochemical potential gradients. For every ATP molecule hydrolyzed, the enzyme pumps three Na ? ions out of and two K
? ions into the cell. Because of its fundamental role in cell physiology, Na,K-ATPase is the target of several specific regulatory mechanisms. Among them, the enzyme is modulated in various cells by interaction with the socalled FXYD proteins, a group of short, single-transmembrane proteins named after the invariant extracellular motif FXYD Geering 2006; Sweadner and Rael 2000) . All mammalian members of the FXYD family are known to associate with Na,K-ATPase and modulate its properties in a tissue-and isoform-specific way. FXYD1, also known as phospholemman, was first identified as the major substrate for protein kinases A (PKA) and C (PKC) in the heart (Palmer et al. 1991; Presti et al. 1985b ). Subsequently, it has been found to associate with specific isoforms of Na,K-ATPase and modulate the enzyme activity in heart and skeletal muscle as well as kidneys and brain (Feschenko et al. 2003; Floyd et al. 2010) .
So far, the effects of FXYD1 on Na,K-ATPase have been investigated mostly in intact cells, both native and heterologous expression systems. These systems allow characterization of the physiological effects of FXYD1 but are of limited use for detailed study of functional and structural interactions between FXYD1 and the enzyme. Recently, a purification procedure of the human a 1 /His 10 -b 1 , a 2 /His 10 -b 1 and a 3 /His 10 -b 1 isoforms of Na,K-ATPase expressed in yeast Pichia pastoris has been developed and introduced for mechanistic studies (Cohen et al. 2005; Haviv et al. 2007; Katz et al. 2010) . The purified, detergent-solubilized a 1 /His 10 -b 1 can be reconstituted in vitro with purified, detergent-solubilized human FXYD1 expressed in Escherichia coli to obtain the a 1 /His 10 -b 1 / FXYD1 complex Lifshitz et al. 2006; Mishra et al. 2011) . The purified recombinant proteins provide a preparation that enables us to work under welldefined conditions, controlling the stoichiometry of FXY-D:ab complexes and without interference by other cellular components. Unlike the situation with native cells, the effects of FXYD1 on the different isoforms of Na,KATPase can be investigated separately. Moreover, since the phosphorylation state of FXYD1 in the purified preparations is easily controllable, the functional role of the protein kinase-mediated phosphorylation of FXYD1 can be studied. Therefore, these systems allow a detailed functional analysis of the effects of FXYD1 on Na,K-ATPase.
In recent studies, purified recombinant proteins have been exploited to investigate the effect of FXYD1 on various partial reactions of the Post-Albers cycle of Na,K-ATPase Lifshitz et al. 2006) . In these preparations, the presence of FXYD1 affects only the Na ? binding and release kinetics in both principal conformations, E 1 and P-E 2 . All other partial reactions of the pump cycle, such as K ? binding and release, enzyme phosphorylation and dephosphorylation and conformation transitions, are not significantly modified by FXYD1 . FXYD1 increased the apparent Na ? -binding affinity in reconstituted complexes when measured directly using the electrochromic shift dye RH421 . This is an intriguing finding because various studies in native membranes of different cells have shown that FXYD1 increases the halfsaturating Na ? concentration (K 1/2 ) of Na ? ions for activation of the ion pump (Cornelius and Mahmmoud 2003; Crambert and Geering 2003; Garty and Karlish 2006; Geering et al. 2003; Geering 2005 Geering , 2006 Geering , 2008 . In purified recombinant proteins, an annulus of lipids and detergent molecules surrounds the hydrophobic part of the membrane helices and maintains the functional integrity of the enzyme. However, it does not provide the planar membrane surface present in cells, and potentially, this may affect the interaction between FXYD1 and Na,K-ATPase.
The structure of FXYD1 as a free monomer in SDS micelles was determined by NMR spectroscopy ). FXYD1 appears to be organized in four ahelices: H1 at the extracellular side (Asp12-Gln17), H2 as a transmembrane domain (Ile18-Leu36) and on the cytoplasmic side H3 (Ser37-Lys43) and H4 (Thr59-Ser68). The FXYD motif forms a disordered segment preceding H1. Helices H1, H2 and H3 are rigidly connected and show similar backbone dynamics, while H4 is linked to the others by a long flexible loop. Both cytoplasmic helices, H3 and H4, are associated with the micelle surface so that, overall, FXYD1 adopts an L-shaped conformation. So far, this is the only complete structure available for an FXYD protein since in neither of the crystal structures of Na,KATPase published to date (Morth et al. 2007; Shinoda et al. 2009 ) were the cytoplasmic sequences of FXYD2 and FXYD10 resolved. The flexible stretch between H3 and H4 should allow great flexibility of the C-terminal domain of the FXYD proteins and could account for its absence in the X-ray structures.
Solid-state NMR data of FXYD1 in lipid bilayers formed of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-dioleoyl-sn-glycero-3-phosphoglyceol (DOPG) (DOPC/ DOPG 4:1) also indicate the association of these helices with the membrane ). Moreover, isothermal titration calorimetric experiments have shown that a 35-amino acid peptide representing the cytoplasmic sequence FXYD1 associates with the membrane depending on the amount of negatively charged phospholipids (Hughes et al. 2011) . The presence of several basic residues in helices H3 and H4 explains their propensity to interact with the negatively charged surface of the SDS micelle and with lipid bilayers containing 25 mol% or more of anionic phospholipids. However, such a disposition of H4 is unlikely to be a physiological one since this helix contains residues Ser63, Ser68 and Thr69, which are targets of PKA and PKC in vivo (Fuller et al. 2009; Palmer et al. 1991; Presti et al. 1985a, b; Walaas et al. 1994) . Phosphorylation of these residues provides another mechanistic concept to regulate Na,K-ATPase by FXYD1. The presence of the (negatively charged) phosphates and the high mobility of H4 may lead in vivo to a modulated interaction of FXYD1 with the cytoplasmic domain of the ion pump.
In view of the considerations just raised, the presence and composition of a lipid bilayer surrounding the enzyme may be important for the correct interaction of FXYD1 with Na,K-ATPase. In order to investigate this aspect of the regulation of Na,K-ATPase by FXYD1, purified recombinant proteins were reconstituted in proteoliposomes and the activation of ion pumping by Na ions, in the absence and presence of FXYD1, was evaluated using proteoliposomes with specific lipid compositions.
Materials and Methods

Materials
Bovine serum albumin (BSA) was obtained from Bio-Rad (Hercules, CA, USA) and nicotinamide adenine dinucleotide (NADH) from Roche (Indianapolis, IN, USA). n-Dodecyl-bmaltoside (DDM) was purchased from Anatrace (Santa Clara, CA, USA) and BD-Talon metal affinity resin from Clontech (Mountain View, CA, USA). Octaethylene glycol monododecyl ether (C 12 E 8 ) was obtained from Bachem (Bubendorf, Switzerland) and 1-stearoyl-2-oleoyl-sn-glycero-3-(phosphol-serine) (SOPS), 1,2-dioleoyl-sn-glycero-3-phosphoglyceol (DOPS), 1,2-dierucoyl-sn-glycero-3-phosphocholine (DEPC), L-a-phosphatidylcholine from soybean (SBPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-dioleoylsn-glycero-3-phosphoethanolamine (DOPE), from Avanti Polar Lipids (Alabaster, AL, USA). AcTEV TM Protease was from Life Technologies (Carlsbad, CA, USA). ATP (disodium salt, special quality) was obtained from Roche. The membrane potential-sensitive fluorescent dye bis-(3-propyl-5-oxoisoxazol-4-yl)pentamethine oxonol (oxonol VI) was ordered from MoBiTec (Goettingen, Germany). Recombinant cAMPdependent PKA (2,500,000 units ml
, catalog no. P6000L), and calf intestinal alkaline phosphatase (CIP; 10,000 units ml
, catalog no. M0290S) were obtained from Bio Labs (Lawrenceville, GA, USA). All other reagents were purchased from Merck (Darmstadt, Germany) or SigmaAldrich (St. Louis, MO, USA) at the highest quality available.
Methods
Purification of Na,K-ATPase Expressed in P. pastoris
The human a 1 /His 10 -b 1 isoform of Na,K-ATPase was expressed in P. pastoris as described previously, with a His 10 tag added to the N terminus of the b-subunit (Cohen et al. 2005) . In short, the cells were broken with glass beads and urea-treated membranes were prepared. The membranes were solubilized with DDM (DDM:protein 2:1 w/w), and the human a 1 /His 10 -b 1 complex was purified by metal chelate chromatography with BD-Talon beads as described Lifshitz et al. 2007 ). Approximately 100 lg of purified enzyme were obtained from 10 g of yeast cells. For further use the protein solution was concentrated to 0.7-1.1 mg ml -1 protein with Amicon Ultra Centrifugal Filters 100 K (Millipore, Billerica, MA; exclusion size 100 kDa) in a buffer of 20 mM tricine (pH 7.4) and 25 % glycerol, and stored at 0°C (for short periods) or at -80°C after freezing with liquid N 2 . The protein concentration was determined either by the Lowry or the BCA assay. The specific ATPase activity was tested by the pyruvate kinase/lactate dehydrogenase assay (Schwartz et al. 1971 ).
FXYD1 Preparation from E. coli
Human FXYD1 was expressed in E. coli as described elsewhere Lifshitz et al. 2006; Mishra et al. 2011) . FXYD1 carried an N-terminal His 6 tag. In short, after breaking the cells with a French press, the light membrane fraction was separated and collected by centrifugation. The membranes were resuspended in the presence of protease inhibitors and stored at -80°C. FXYD1 was purified similarly to the a 1 /His 10 -b 1 complex: the membranes were solubilized with DDM (DDM:protein 2:1 w/w), and the FXYD1 was purified by metal-chelate chromatography with BD-Talon beads in the presence of 40 lM EDTA at a concentration of 1 mg ml -1 protein. The protein was eluted as described above, and the His-tag was removed by treatment with AcTEV protease as described . Approximately 50 lg of purified protein were obtained from 2.5 g cells.
FXYD1 was phosphorylated in vitro by PKA during the purification from E. coli. After solubilization and binding to the BD-Talon beads, the beads-bound FXYD1 (approximately 100 lg) was incubated for 5 h at room temperature with 250,000 units of the catalytic subunit of PKA in a buffer containing 50 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 and 1 mM ATP (Lifshitz et al. 2006) . Thereafter, the beads were washed to remove the PKA, and the phosphorylated FXYD1 was eluted as described for the unphosphorylated FXYD1. The phosphorylation state was checked with specific antibodies against FXYD1 phosphorylated at Ser68 (a gift from Dr. W. Fuller, University of Dundee) (Fuller et al. 2009 ).
In Vitro Reconstitution of the a 1 /His 10 -b 1 /FXYD1 Complex Reconstitution was performed as published recently Mishra et al. 2011) . In short, the solubilized a 1 / His 10 -b 1 complex was loaded on BD-Talon beads and incubated in a buffer containing 10 mM imidazole, 20 mM tricine (pH 7.4), 100 mM NaCl, 0.1 mg ml -1 C 12 E 8 , 0.05 mg ml -1 SOPS, 0.01 mg ml -1 cholesterol and 10 % glycerol with purified FXYD1 at a 10-fold molar excess. After 4 h at 6°C, excess FXYD1 was removed by washing and the complex eluted.
Preparation of Proteoliposomes
In a first set of experiments, proteoliposomes formed by a mixture of DEPC, SBPC and cholesterol in a ratio of 50:49:1 mol mol -1 were prepared. SBPC provides a mix of phospholipids with a broad distribution of fatty acid chains, creating a lipid environment comparable to a cell membrane. A small amount of cholesterol was introduced due to the stabilizing effect of this lipid on the recombinant a 1 /His 10 -b 1 complex ). Such lipid composition generates proteoliposomes with a low leak conductance and a high enzyme activity. To investigate the effect of anionic phospholipids on the interaction of FXYD1 with the enzyme, in some experiments the zwitterionic DEPC was replaced with 10, 20, 35 and 50 mol% of the anionic DOPS. Lipid vesicles containing native Na,K-ATPase from rabbit kidney, purified recombinant a 1 / His 10 -b 1 or a 1 /His 10 -b 1 /FXYD1 were prepared by a method similar to the one described before for the reconstitution of bacteriorhodopsin (Lambert et al. 1998) . Since DDM cannot be efficiently removed by dialysis due to its low critical micelle concentration (0.01 % at 25°C), proteoliposomes were obtained by adsorption of the detergent onto SM2 Bio-Beads (BioRad, . In summary, the addition of an excess of SM2 Bio-Beads to a solution containing a mix of DDM-solubilized native Na,K-ATPase or purified recombinant enzyme and lipid/DDM micelles leads to fast adsorption of the detergent by the beads and the formation of active unilamellar proteoliposomes with an average diameter of 110 nm (Lambert et al. 1998) . Typically, half of the protein molecules are reconstituted with the ATP-binding site facing outward.
The desired lipid mixture was dissolved in 2 % DDM in buffer H (25 mM imidazole, 1 mM EDTA, 5 mM MgSO 4 , 5 mM Na 2 SO 4 , 70 mM K 2 SO 4 , pH 7.2) to obtain a lipid concentration of 8 mg ml -1 . Sulfate was chosen as the primary anion since it produces a significantly lower leak current than chloride (Apell et al. 1985; Apell and Bersch 1987) . To obtain proteoliposomes with native Na,K-ATPase from rabbit kidney, protein-containing membrane fragments prepared according to Jørgensen (1974) were solubilized with DDM at a protein:detergent ratio of 1:2 (w/w).
Purified recombinant enzyme or solubilized native Na,K-ATPase from rabbit kidney was diluted with buffer H to get a protein concentration of 0.1 mg ml -1 and mixed with the lipid/DDM mixture at a ratio of 1:1 v/v. The beads (1 mg beads/2 ll lipid/DDM mixture) were added, and the mixture was incubated overnight at 6°C under continuous stirring. Eventually, the solution containing the vesicles was separated from the beads using capillary tips and stored at 0°C. After being kept on ice for a minimum of 3 h, tight vesicles were obtained. Assuming that all the enzyme molecules reconstitute in the lipid membrane, the final protein:lipid ratio was about 1:15,000, equivalent to six to seven ion pumps per vesicle, half of them oriented inside-out. The specific ATPase activity of the native Na,K-ATPase before and after solubilization of the membrane fragments as well as after reconstitution in lipid vesicles was determined routinely (Schwartz et al. 1971) .
In a second set of experiments, proteoliposomes with lipid mixtures approximating the inner leaflet of the bulk of the plasma membrane of human cardiac myocytes were prepared. A composition of 10 mol% cholesterol, 34 mol% DPPC, 38 mol% DOPE and 18 mol% DOPS was chosen. Also in these experiments the DOPS content was varied between 0 and 30 mol% in exchange for DOPE to investigate the effect of anionic phospholipids on the interaction of FXYD1 with the enzyme. Due to the lower solubility of such lipid mixtures in DDM, a solution of 1 % DDM and 1 % C 12 E 8 in buffer H was chosen to solubilize the lipids. To obtain significant fluorescence signals, the protein concentration was doubled compared to the one used in the first set of experiments.
Detection of Na,K-ATPase-Mediated Ion Transport in Proteoliposomes by Oxonol VI Na,K-ATPase transports one positive elementary charge across the membrane during each pump cycle. As a consequence, activation of the inside-out-oriented ion pumps by the addition of ATP to the extravesicular electrolyte generates an inside-positive electric potential. The negatively charged fluorescent dye oxonol VI has been introduced previously as an indicator of inside-positive membrane potentials in vesicles, and it has been shown to detect successfully the electrogenic pump activity of Na,KATPase reconstituted in proteoliposomes (Apell and Bersch 1987) . Experiments similar to those reported in Apell and Bersch (1987) were performed. In short, 1 ml of buffer containing 25 mM imidazole, 1 mM EDTA, 2.5 mM MgSO 4 and various concentrations of Na 2 SO 4 (pH 7.2) was thermally equilibrated in a cuvette. Afterward, 25 nM oxonol VI and a volume of proteoliposomes corresponding to 80 lg ml -1 lipid were added. When a steady-state fluorescence level was obtained, 2.5 mM MgATP was added to trigger pump activity. The pump activity is reflected in a fluorescence increase that exponentially approaches a steady-state level at which the pump current is compensated by the leak current due to the membrane conductance. The experiments were carried out in a Perkin Elmer (Rodgau, Germany) LS 50B luminescence spectrometer. The thermostatically controlled cuvette holder was equipped with a magnetic stirrer. The excitation wavelength was set to 580 nm (slit width 20 nm) and the emission wavelength to 660 nm (slit width 20 nm). Measurements were performed at 20°C as described previously (Apell et al. 1990; Apell and Bersch 1987) . Tris/ H 2 SO 4 (pH 7.0) was added to the buffer in appropriate concentrations to obtain an ionic strength equivalent to that of the intravesicular medium, unless otherwise indicated. To allow a comparison between different experiments, fluorescence changes were normalized with respect to the fluorescence level, F 0 , at membrane voltage 0, before the addition of ATP. The normalized fluorescence increase can be fitted with a single exponential function
where F norm (t) is the normalized fluorescence amplitude, F(t) the measured fluorescence and s a characteristic time constant that reflects the pump activity. The initial slope of the fluorescence increase after ATP addition, corresponding to the increase in membrane potential, is proportional to the product of pumping rate and the amount of active pump molecules, averaged over all vesicles (Apell and Bersch 1987) . As presented in part 1 of the Supplementary Material, the initial slope can be used as a parameter to determine the pump rate. Its dependence on the extravesicular Na ? concentration within the same vesicle preparation can be exploited to evaluate the K 1/2 of Na ? ions for activation of the ion pump.
Results
To investigate the influence of the membrane and its lipid composition, Na,K-ATPase was reconstituted in lipid vesicles, and its Na ? -binding kinetics was investigated using oxonol VI to monitor the membrane potential as described in ''Materials and Methods'' section. The method was applied first to Na,K-ATPase from rabbit kidney reconstituted in vesicles to compare the results with the well-known binding kinetics in native membrane fragments and then extended to vesicle preparations with the recombinant a 1 /His 10 -b 1 isoform with and without FXYD1. Proteoliposomes with different amounts of the anionic phospholipid DOPS were prepared to study the effect of the surface charge density on the protein interaction.
Na,K-ATPase from Rabbit Kidney Reconstituted in Proteoliposomes with Various Lipid Compositions
Proteoliposomes with native a 1 /b 1 /FXYD2 complexes isolated from rabbit kidneys were formed as described in ''Materials and Methods'' section with various amounts of DOPS (0-50 mol%). The enzyme activity, E a , of Na,KATPase was determined at the different stages of the preparation. While the activity was about 28.5 lmol of Pi (mg protein)
-1 min -1 in native membrane fragments, it decreased to 2.2 lmol of Pi (mg protein)
-1 min -1 after solubilization in DDM. This fact demonstrates that the solubilized environment is less favorable for the enzyme activity, as has been reported recently (Habeck et al. 2009 ). Indeed, part of the enzyme activity was regained after reconstitution in proteoliposomes, depending on the lipid composition (Table 1 ). In particular, the specific activity increases linearly with the amount of DOPS in the membrane, up to almost fourfold the activity after solubilization. This observation is not surprising since the need for anionic phospholipids for Na,K-ATPase activity is well documented (Cohen et al. 2005; de Pont et al. 1978; Lifshitz et al. 2007 ). For the comparison it must be taken into account that, in the vesicles, only 50 % of the protein is inside-out-oriented and has access to and hydrolyzes the added ATP. At 50 mol% DOPS, E a was found to be 30 % of that of the native membrane fragments. Since only half of the enzyme is inside-out-oriented and hydrolyzing ATP, the total amount of active Na,K-ATPase can be estimated to be about 60 % of the native enzyme. Thus, 40 % of the activity lost by solubilization could not be regained.
The K 1/2 of Na ? ions for activation of the native Na,KATPase was investigated in vesicles of different lipid composition by the oxonol VI method as described in ''Materials and Methods'' section. Figure 1a shows a typical experiment with vesicles prepared with SBPC in a buffer containing 75 mM Na ? . When 2.5 mM ATP were Table 1 Comparison of the effects of DOPS on kinetic parameters of Na,K-ATPase from rabbit kidney . Values were obtained from two different vesicle preparations each b v max is defined as v max = (dF/dt) max /s -1 (see Fig. 1 ), which is a quantity proportional to the pump current through the vesicle membrane generated by Na,K-ATPase c K 1/2 and n represent the half-saturating Na ? concentration and the Hill coefficient, respectively, obtained from Eq. 2 d G m is the leak conductance of the membranes, evaluated as described in ''Results'' section added, the generation of an inside-positive potential was observed, allowing determination of the pump activity of Na,K-ATPase. After reaching a steady state, the ion pump was completely inhibited by addition of 5 mM ortho-vanadate. The observed decrease of the fluorescence signal corresponds to the passive discharge of the membrane capacitor of the vesicles. This exponential decay is controlled by a time constant, s m = C m /G m , where C m is the specific membrane capacitance (*1 lF cm -2 ) and G m is the specific membrane conductance. The latter can be determined from G m = C m /s m . The time course of the ATP-induced fluorescence signal (see box in Fig. 1a ) has been fitted by Eq. 1. Examples of single experiments at four Na ? concentrations are shown in Fig. 1b . Two parameters, s and F ? , are obtained from the fits that allow determination of the initial slope, (dU/dt) t=0 = K* 9 (dF/ dt) t=0 , a measure of the pump current (see Part 1 in the Electronic Supplementary Material). Within the same vesicle preparation, the proportionality constant, K*, which depends on the properties of each specific vesicle preparation, is invariable. Therefore, the initial slopes can be compared directly. Such experiments were performed in buffers with Na ? concentrations between 0 and 50 mM and with lipid mixtures between 0 and 50 mol% DOPS. The Na ? concentration dependence in the absence and presence of 35 mol% DOPS is shown in Fig. 1c . It was fitted by the Hill function
where (dF/dt) max is the initial slope at saturating Na concentrations, when ion binding is no longer limiting; K 1/2 is the half-saturating Na ? concentration; and n is the Hill coefficient, which indicates that cooperative ion binding takes place when n [ 1. The results, obtained as the average of three identical experiments for each Na ? concentration and lipid composition from one set of vesicle preparation, are compared in Table 1 . The results show that both the enzyme activity, E a , and the maximum initial slope (or pump flux), v max , increase accordingly with the amount of DOPS in the membranes. K 1/2 was less significantly affected. It decreased slightly between 0 and 20 mol% of DOPS and increased about 30 % between 20 and 50 mol%. The Hill coefficient was hardly affected, with an average of 2.0 ± 0.1. When these results are Fig. 1 Analysis of Na,K-ATPase-dependent generation of the electric membrane potential in proteoliposomes. a Typical oxonol VI experiment. After equilibration of proteoliposomes reconstituted with Na,K-ATPase from rabbit kidneys in an electrolyte containing oxonol VI, 2.5 mM MgATP was added to start pump activity, which builds up an inside-positive membrane potential. After about 50 s, a steady state was maintained in which the pump current was balanced by the leak current. When 5 mM ortho-vanadate was added Na,K-ATP was inhibited and the membrane potential declined exponentially with a time constant controlled by the leak conductance of the membrane. Box indicates the part of the experiment used to study the Na compared with Na ? binding in native membrane fragments (of undetermined lipid composition), the binding kinetics is similar, with a Hill coefficient of *2. The enzyme activity is, however, a factor of 1.7 times larger in native membranes (see above), while K 1/2 is 4.2 ± 0.3 mM. This difference may be assigned to a variant lipid composition in the native membranes. In summary, it can be stated that this experimental approach is suitable to determine the Na ? -binding kinetics of Na,K-ATPase in various lipid environments. Comparison of the K 1/2 values for both preparations in Fig. 2a shows that the presence of FXYD1 (solid line) raised the K 1/2 of Na ? ions for activation of the human a 1 / His 10 -b 1 complex. This finding is in agreement with respective findings obtained from studies in whole cells and supports the suggestion that the presence of a lipid bilayer plays a role in the functional properties of FXYD1. This is supported by the observation that also the amount of DOPS in the lipid bilayer affected the K 1/2 of Na ? ions. Between 0 and 20 mol% DOPS the value of K 1/2 decreased by about 25 % in the presence of FXYD1. The slight increase at 50 mol% DOPS should be viewed with caution since in this condition the leak conductance of the vesicle membrane and the maximal pump rate (at saturating Na ? concentration) are also affected (Fig. 2) . By comparison, K 1/2 exhibited no significant dependence on DOPS concentration in the absence of FXYD1, with a value of 14 ± 0.6 mM within the whole range. Above 20 mol% DOPS no significant difference of K 1/2 was visible for both preparations. The cooperativity of Na ? activation as reflected in the Hill coefficient, n H , was affected neither by the presence of FXYD1 nor by the DOPS contents of the lipid bilayer (Fig. 2b) . The third parameter obtained from the vesicle experiments is the maximum pump rate, which is proportional to the initial fluorescence increase, dF/dt| t=0 , obtained at saturating Na ? concentrations (Fig. 2c) . This pump rate, v, is proportional to the number of active pumps, N P , and the individual turnover rate of Na,KATPase, v P ,
Recombinant
ð3Þ In the presence of FXYD1 the pump rate was largely independent of DOPS and about 50 % higher than that in the preparation without FXYD1. This finding reflects the welldocumented stabilization effect of FXYD1 and indicates a higher number of active pump molecules ). In the absence of FXYD1 the stabilizing effect of DOPS is obvious by the increase of the pump rate by a factor of 3 between 0 and 35 mol% DOPS. The last parameter evaluated from the vesicle experiments was the leak conductance of the membranes. It was found that G m was constant for both preparations up to a content of 35 mol% DOPS (2.7 ± 0.4 nS cm -2 ). At 50 mol% an increased leak conductance was found in both preparations (Fig. 2d) .
Effect of Ionic Strength
The vesicle preparations used so far were studied in an electrolyte with an ionic strength of *250 mM, but the ionic strength of the cytosol in heart muscle cells is on the order of 100 mM. Therefore, we tested whether an appropriately reduced ionic strength would affect the Na ? -binding properties and the regulatory properties of FXYD1. These controls are important in so far as it is known that the electric surface potential of membranes is controlled by the ionic strength according to the Gouy-Chapman theory (McLaughlin 1977) . Since the modulatory action of FXYD1 depends on the ratio of the negatively charged DOPS in the membrane (Fig. 2a) , the electrostatic interaction between the basic amino acids at the mobile C-terminal domain of FXYD1 and the negative membrane surface has to be considered. When the ionic strength is reduced from 250 to 110 mM, the Debye length of electric surface potentials in the solution increases from 0.6 to 0.9 nm, and for a given surface charge the absolute value of the surface potential is increased by about 30 %.
To maintain an ionic strength of *110 mM, Tris/H 2 SO 4 was added to the extravesicular electrolyte in appropriate amounts. To perform experiments in which the Na ? -dependent pump current is determined (Fig. 1a) , it is necessary that the intravesicular K ? concentration is as high as possible in order to maintain the pumps in the Na ? /K ? exchange mode for a sufficiently long period before depletion of K ? inside the vesicles and a switch to the Na ? -only pumping mode. Therefore, the ionic strength of the intravesicular solution could not be reduced since that would have produced a significantly lower internal potassium concentration. The experiments were performed at 0, 20 and 50 mol% DOPS (Fig. 3) . In the absence of additional DOPS the K 1/2 values were in both preparations 25 % lower when compared to the results at high ionic strength. This decrease of K 1/2 of Na ? ions for activation of the pump represents the effect of the increased surface potential of the protein surface close to the entrance of the access channel to the ion-binding sites. When the effect of 20 and 50 mol% DOPS on K 1/2 was compared for both vesicle preparations, with a 1 /His 10 -b 1 and a 1 /His 10 -b 1 / FXYD1 enzymes, the differences in the K 1/2 values were not significant, similar to what was found at high ionic strength (Fig. 2a) . On the one hand, the K 1/2 values were unaffected by the amount of DOPS in the vesicle preparations without FXYD1 (Fig. 3) . Considering the Debye length, which was less than 1 nm even at the lower ionic strength, this finding is not surprising since the surface-charge effect on the Na ? concentrations vanishes (Dc Na \4 %) within two times the Debye length. This finding indicates that the presence of additional negatively charged DOPS molecules in the membrane does not modify significantly the local Na ? concentration at the entrance of the access channel (for details see Part 2 in the Electronic Supplementary Material). On the other hand, the K 1/2 values were affected by the presence of DOPS when the protein complex contains the FXYD1 subunit. When the DOPS content was increased from 0 to 20 mol%, the K 1/2 values decreased by more than 20 % in the a 1 /His 10 -b 1 /FXYD1 enzyme, independently of the ionic strength. This observation supports strongly the concept that in the presence of FXYD1 and at elevated DOPS concentrations the decrease of K 1/2 of Na ions for activation of the pump is attributable to an interaction between the cytoplasmic domain of FXYD1 and the membrane surface. The values of the other kinetic parameters, namely, the Hill coefficient, maximum pump rate and leak conductance, with the different DOPS contents were comparable to those obtained in experiments at high ionic strength (data not shown). ? concentration, K 1/2 , is plotted for both preparations as a function of the fraction of DOPS in the membranes. b The Hill coefficient of the Na ? -binding kinetics (Eq. 2) was unaffected by the presence or absence of FXYD1 in the Na,K-ATPase complex and the DOPS concentration. c The maximum pump rate of a 1 /His 10 -b 1 and a 1 /His 10 -b 1 /FXYD1 represented by the initial slope of the oxonol VI fluorescence after addition of ATP (Fig. 1a) increased as a function of the fraction of DOPS in the membranes. The results indicate clearly the stabilizing effect of FXYD1 and the presence of DOPS. Error bars in all panels represent the SEM. d Leak conductance of the vesicle membranes. Up to 35 mol% DOPS no significant differences could be observed. At 50 mol% DOPS the leak conductance was increased in both preparations 
Effect of Lipid Composition
Since it has been shown that the DOPS content affected the apparent K 1/2 of Na ? ions for activation of the pump, it was logical to look for additional effects of the lipid composition. The critical role of FXYD1 in the heart contractionrelaxation mechanism is of particular interest. In order to obtain data most relevant to physiologically relevant conditions, we looked at possible effects of a lipid environment resembling the bulk of the plasma membrane of human cardiac myocytes. Preparations of liposomes with an asymmetric lipid distribution are so far impossible. Since the most interesting kinetic property in our study was the K 1/2 for Na ? ions when the ion binding sites are facing the cytoplasm, the lipid composition was chosen to resemble that of the inner layer. In addition, the crucial C-terminal domain of FXYD1 is located on this side. Therefore, a lipid mixture containing 10 mol% cholesterol, 34 mol% DPPC, 38 mol% DOPE and 18 mol% DOPS was chosen. This may be considered a reasonable approximation of the cytoplasmic leaflet of the plasma membrane of human cardiac myocytes, which contains about 18 mol% of negatively charged phospholipids (Gloster and Harris 1969; Post et al. 1988) .
The DOPS dependence of K 1/2 is shown as the most important result in Fig. 4 . When the K 1/2 of Na,K-ATPase in the absence FXYD1 is compared with the data obtained from vesicles formed with mixtures of SBPC, DEPC, cholesterol and DOPS only (Fig. 2a) , the Na ? affinity was increased by almost a factor of 2 in the lipid environment simulating a cardiac cell. This observation indicates that the K 1/2 of Na ? ions can be significantly affected by the lipid environment, even in the absence of FXYD1. The overall tendency of the DOPS concentration on the effect of FXYD1 was the same as found in Fig. 2a . In the absence of DOPS, K 1/2 was 18.1 ± 1.7 mM, which is approximately the same as in the case of the vesicles prepared with SBPC. K 1/2 decreased with increasing DOPS content and had a low constant value of about 8 ± 0.6 mM above 10 mol% DOPS. It seems that the effect of FXYD1 is maximal in the absence of added DOPS and disappears above 10 % DOPS.
Effect of FXYD1 Phosphorylation by PKA
To test the effect of FXYD1 phosphorylation on the Na ? -binding affinity, the PKA-phosphorylated FXYD1 was reconstituted with a 1 /His 10 -b 1 and used to produce proteoliposomes with the lipid compositions introduced above containing DOPS up to 50 mol%. In a first set of experiments, an ionic strength of 110 mM was chosen for the extravesicular electrolyte, and K 1/2 was determined at 0, 20 and 50 mol% DOPS. The results are included as triangles in Fig. 3 . The K 1/2 of Na ? ions was only insignificantly dependent on the DOPS concentration, similar to the results obtained in the absence of FXYD1. This outcome indicates that no interaction occurs between the in vitro PKA-phosphorylated FXYD1 and the cytoplasmic domain of the pump that affects the Na ? -binding kinetics. In a second set of experiments, the lipid composition was set to 10 mol% cholesterol, 34 mol% DPPC and various amounts of DOPE and DOPS (together 56 mol%) to allow a comparison with the results obtained in the presence of unphosphorylated FXYD1 in vesicles with a lipid composition mimicking cardiac myocyte membranes (Fig 4) . Phosphorylation of FXYD1 reversed the effect on the K 1/2 of Na ? ions also in such a lipid environment: up to 30 mol% DOPS, the average K 1/2 was 7.7 ± 0.3 mM, not significantly different from the value obtained in the absence of FXYD1 (7.2 ± 0.6 mM). Therefore, phosphorylation of Ser68 by PKA is able to abolish the effect of FXYD1 on the K 1/2 of Na ? ions also in the case of a lipid composition close to that of cardiac myocytes.
Discussion
Previously, the effects of FXYD1 on Na,K-ATPase were investigated largely in intact cells, both heterologous systems and native cells. These systems easily allow characterization of the effects of FXYD1 in conditions resembling the physiological setting. They are, however, only of limited use for detailed studies of functional and Line through the ?FXYD1 data is drawn to guide the eye; both straight lines represent the average of the data structural interactions between FXYD1 and Na,K-ATPase. In contrast, purified, detergent-solubilized recombinant preparations provide a system that enables us to work under well-defined conditions and without interference from other cellular components. Unlike the conditions in native cells, reconstitution of abFXYD1 complexes in vitro allows the FXYD1:ab stoichiometry to be varied experimentally, and effects of FXYD1 on the different isoforms of Na,K-ATPase can be investigated separately. Moreover, since the phosphorylation state of FXYD1 in the purified preparations is easily controllable, the functional properties of the protein kinase-mediated phosphorylation of FXYD1 can be investigated.
Recently, the electrochromic styryl dye RH421 was applied in steady-state and time-resolved kinetic measurements to characterize the effects of FXYD1 on the different partial reactions of the transport cycle of the human a 1 /b 1 isoform of Na,K-ATPase in isolated, solubilized, reconstituted a 1 b 1 FXYD1 complexes. In these experiments only a single kinetic property of FXYD1 was affected, namely, the Na ? -binding affinity. In both conformations, E 1 and P-E 2 , the apparent Na ? -binding affinity was increased by *20-30 % ). This observation was striking because it appears to be contrary to the findings of experiments in whole cells, in which it has been found that the presence of FXYD1 leads to a raised K 1/2 of Na ? ions for activation of the pump. A major difference between the two systems is the absence of a lipid bilayer surrounding Na,K-ATPase in the case of isolated complexes. They have only specifically bound SOPS and cholesterol molecules and remaining annular lipids, as well as detergent molecules in a protein-lipid-detergent mixed micelle. This state may affect the functional role of the highly mobile C-terminal domain of FXYD1. Therefore, the Na ? -binding kinetics was revisited in a system that still contained Na,K-ATPase with or without FXYD1 as the only protein but provided an extended lipid-bilayer environment. For this purpose, in the present study, the recombinant enzyme was reconstituted in unilamellar vesicles.
Upon reconstitution in lipid vesicles with up to 10 mol% added DOPS, FXYD1 induced a significant increase in the K 1/2 of Na ? ions for activation of the pump (Figs. 2a, 3, 4) , similar to what has been detected in intact cells in the presence of unphosphorylated FXYD1 (Bibert et al. 2008; Bossuyt et al. 2009; Crambert et al. 2002b; Despa et al. 2005; Han et al. 2009 Han et al. , 2010 Lifshitz et al. 2006 ). These results demonstrate, first, that FXYD1 associates correctly with the enzyme during in vitro reconstitution since the behavior resembles that found in native cell membranes. The second finding is that the presence of a lipid bilayer affects significantly the functional mechanism of FXYD1. And the third insight is that a variation of the surfacecharge density of the lipid bilayer may be used to modulate the interaction of FXYD1 with Na,K-ATPase.
Functional Differences Between the a 1 /His 10 -b 1 / FXYD1 Enzyme in Complexes and Membranes Two domains of the FXYD1 molecule appear to underlie its regulatory effects: the membrane domain (H2) and the C-terminal domain (including H4). In the isolated complexes as well as in the membrane-reconstituted form, the membrane domains of FXYD1, H2 and H9 of the a 1 -subunit, should be in functional contact since the stabilizing effect of FXYD1 on Na,K-ATPase has been found in both detergent-soluble, isolated complexes and native cell membranes ). In addition, reconstitution of FXYD1 with a 1 /His 10 -b 1 is performed identically before complex isolation and vesicle formation. The addition of (functional) lipids during complex formation is assumed to form a stable protein complex with a few specifically bound lipid molecules (SOPS, cholesterol) that create the active complex ). The additional lipid and residual detergent molecules are assumed to constitute an annulus with a hydrophobic core that mimics a lipid bilayer and thus hides the hydrophobic surface of Na,KATPase from the aqueous phase. Therefore, it may be anticipated that the interaction of the membrane domains is comparable in isolated complexes and membranes.
Considering the interaction between the cytoplasmic domains of FXYD1 and the pump, major differences may be expected. In the isolated complexes, the lipid annulus surrounding the pump contains mostly negatively charged SOPS, added during the purification to preserve enzyme activity. In this condition, the cytoplasmic domain of FXYD1 could be bent away from the N, P and A domains of the pump and interact irreversibly with the curved surface of the annulus. The NMR structure of FXYD1 in SDS micelles shows such a structure . In that study, the observation that the cytoplasmic part of FXYD1 reveals only minor variations in its localization indicates that the C-terminal end is preferentially localized on the surface of the negatively charged SDS micelle. If such a conformation is established and the C-terminal FXYD1 domain is completely separated from the cytoplasmic domain of Na,K-ATPase, the difference in Na affinity in the presence and absence of FXYD1 observed in Cirri et al. (2011) would be attributable to an interaction of the membrane domains. In this situation the interaction of the membrane domain of FXYD1 with the pump would support the formation of a conformation of the membrane domain of the a 1 -subunit that enhances Na ? binding. When the a 1 /His 10 -b 1 /FXYD1 enzyme is reconstituted in vesicles of mostly uncharged lipids, the mobile C-terminal domain of FXYD1 may be no longer adsorbed to the surface and may be able to interact frequently with the cytoplasmic N, P and A domains of Na,K-ATPase. Possible kinetic mechanisms of the observed effects of FXYD1 assume that the cytoplasmic interaction either forces the pump's membrane domain to switch from a more to a less favorable conformation of the Na ? -binding sites or, alternatively, that it affects the E 1 -E 2 conformational equilibria. A functional coupling of conformational rearrangements between the ion-binding sites in the membrane domain and the cytoplasmic nucleotide-binding domain has been demonstrated already in an earlier study. It has been shown that binding of the third Na ? is coupled with a conformational rearrangement at the ATP-binding site (Schneeberger and Apell 1999) . In consequence, the more frequently the cytoplasmic domain of FXYD1 contacts Na,K-ATPase and affects its conformational movements, the more often the ion-binding sites are forced to stay in a less favorable conformation for binding of the third Na ? ion and the lower is the apparent Na ? -binding affinity. In relation to E 1 -E 2 conformational equilibria, it should be noted that the K 1/2 of Na ? ions for activation of the steady-state Na,K-pump current in proteoliposomes, measured with oxonol VI, and the Na ? affinity of soluble ab complexes, measured with RH421, are not identical kinetic parameters. In particular the K 1/2 of Na ? ions reflects both cytoplasmic Na ? affinities and rate constants of the various transitions around the enzymatic cycle. In a subsequent article we shall present data showing that in defined conditions FXYD1 reduces the maximal turnover rate of soluble a 1 b 1 complexes (Mishra et al., unpublished data) , demonstrating that it can affect rate-limiting steps of the enzymatic cycle as well as Na ? -binding affinities already described ). Phosphorylation of FXYD1 at Ser68 would release the C-terminal helix from the a-subunit and reverse these effects. Further experimental tests are necessary to determine the exact kinetic mechanism.
The Modulatory Role of the Negative Charges on the Bilayer
The DOPS concentration dependence of K 1/2 presented in Figs. 2a, 3 and 4 can be explained by electrostatic interactions between the negatively charged DOPS head groups and the positive charges in the cytoplasmic domain of FXYD1. Four basic amino acids are located close to the cytoplasm-membrane interface (Arg 38, 39, 41 and Lys 43) and seven in H4, the preceding loop and the C terminus (Arg 49, 61, 65, 66, 70, 71 and 72) . At concentrations of DOPS [15 mol%, K 1/2 was not affected by the regulatory subunit and exhibited values similar to that of Na,KATPase without FXYD1 (Figs. 2, 3, 4) . At such high concentrations of DOPS, the electrostatic attraction by the lipid surface may become so strong that the mobile C terminus of FXYD1 remains most of the time trapped there after having contacted the membrane surface during its diffusional movements. At a low DOPS concentration (\10 mol%) the K 1/2 value was significantly larger in a 1 / His 10 -b 1 /FXYD1 than in a 1 /His 10 -b 1 . This experimental finding is in agreement with the concept that at a lower negative charge of the membrane surface FXYD1 interacts more strongly with the a-subunit.
Several studies have approved that unphosphorylated FXYD1 reduces the apparent affinity of the Na,K-ATPase for intracellular Na ? ions in both cardiac myocytes (Bossuyt et al. 2009; Despa et al. 2005; Han et al. 2009 ) and heterologous expression systems (Bibert et al. 2008; Crambert et al. 2002a; Han et al. 2010; Lifshitz et al. 2006) . In the bulk of the plasma membrane of human cardiac myocytes the total content of negatively charged lipid head groups has been estimated to be on the order of 18 mol% with a fraction of *3 mol% phosphatidylserine (Gloster and Harris 1969) . In vesicle preparations with correspondingly high amounts of DOPS, we observed no difference in Na ? -binding affinity, which apparently contradicts the results obtained in intact cells. Recent investigations, however, have reported that a significant fraction of the Na,K-ATPase in rat cardiac myocytes is localized in caveolae (Liu et al. 2003; Liu and Askari 2006) . The precise lipid composition of caveolae is not known and is likely to vary among distinct cell types (Smart et al. 1999 ). Nevertheless, they are enriched in cholesterol and sphingolipids that form a liquid-ordered lipid phase (Anderson 1998; Smart et al. 1999) and contain an amount of negatively charged phospholipids significantly smaller compared to the bulk of the plasma membrane, probably \5 % (Brown and Rose 1992) . Taking this into account, our findings can be considered to be in accordance with observations in cardiac myocytes.
FXYD1 Phosphorylation
The increase of the negative charge of the membrane surface is shown to affect the interaction between unphosphorylated FXYD1 and the cytoplasmic domain of Na,KATPase. However, this is not a physiologically relevant mechanism to regulate the ion-pump activity under changing physiological requirements since it would require a massive increase of the DOPS (or, more generally, anionic phospholipid) content of the cytoplasmic lipid monolayer (above 15 mol%) to dispose the effect on K 1/2 of Na ? binding. As recently published, the actual regulatory effect in cardiac myocytes is caused by phosphorylation of FXYD1 (Bibert et al. 2008; Bossuyt et al. 2009; Despa et al. 2005; Fuller et al. 2004 Fuller et al. , 2009 Pavlovic et al. 2007; Silverman et al. 2005) . This concept is supported by the phosphorylation experiments shown in Figs. 3 and 4 . Phosphorylation of FXYD1 by PKA reduces the observed increase of K 1/2 of the a 1 /His 10 -b 1 /FXYD1 complex in the physiologically relevant range of DOPS concentrations in the membrane. This effect was independent of the amount of negatively charged lipids and may be assigned to a defective interaction of the C-terminal end of FXYD1 with the cytoplasmic domain of the Na,K-ATPase.
Structural and Mechanistic Implications
A molecular-dynamic simulation shows attachments between FXYD1 and the N domain of the a-subunit stabilized by electrostatic interactions and hydrogen bonds (see Part 3 in the Electronic Supplementary Material). This provides a possible concept to explain the regulation of the Na ? -binding affinity of Na,K-ATPase by FXYD1, based on the interaction of the C-terminal part of FXYD1 with the nucleotide-binding domain of the a-subunit of Na,K-ATPase. Under physiological conditions, the highly mobile terminus of FXYD1, which includes the arginine-rich helix H4, may be able to interact with negatively charge glutamates on the surface of the N domain. As explained above, an interaction with FXYD1 could be translated to the membrane domain and reduce the intrinsic affinity for the third Na ? -binding site. Alternatively, since the available crystal structure used for these simulation is an E 2 conformation, the predicted interaction could reduce the interconversion of the N domain between spatial arrangements in the E 1 and E 2 conformations, stabilize the E 2 conformation and, thus, reduce the fraction of enzyme in the E 1 conformation able to bind Na ? in the steady state. Either modification of the intrinsic Na ? -binding affinity to the third Na ? site or the shift in the conformation equilibrium toward E 2 would be reflected also as a decreased apparent Na ? -binding affinity in turnover conditions, as detected in the current experiments. Upon phosphorylation of Ser68 in helix H4, interaction with the N domain may be disrupted and the effect abrogated. Further work is required to distinguish between the possible mechanisms. The structural concept proposed here could, of course, be used as a basis for mutational studies to clarify the role of the involved amino acids in the interaction between FXYD1 and Na,K-ATPase.
